Biggs, George S. https://orcid.org/0000-0001-6526-9236
Cawood, Emma E. https://orcid.org/0000-0002-2707-8022
Vuorinen, Aini https://orcid.org/0000-0001-5815-6962
McCarthy, William J. https://orcid.org/0000-0002-2858-076X
Wilders, Harry https://orcid.org/0009-0000-2524-2063
Riziotis, Ioannis G.
van der Zouwen, Antonie J.
Pettinger, Jonathan https://orcid.org/0000-0002-8219-8369
Nightingale, Luke
Chen, Peiling
Powell, Andrew J. https://orcid.org/0000-0003-1540-537X
House, David https://orcid.org/0000-0002-9635-2451
Boulton, Simon J. https://orcid.org/0000-0001-6936-6834
Skehel, J. Mark https://orcid.org/0000-0002-2432-0901
Rittinger, Katrin https://orcid.org/0000-0002-7698-4435
Bush, Jacob T. https://orcid.org/0000-0001-7165-0092
Funding for this research was provided by:
RCUK | Engineering and Physical Sciences Research Council (EP/V038028/1)
Cancer Research UK (CC2075, CC2000)
RCUK | Medical Research Council (CC2075, CC2000)
Wellcome Trust (CC2075, CC2000)
Article History
Received: 26 July 2024
Accepted: 28 November 2024
First Online: 2 January 2025
Change Date: 23 January 2025
Change Type: Update
Change Details: In the version of the article initially published, in the “HT-LFQ chemoproteomics for hit expansion and live cell treatments” section, “diazepane” originally appeared as “diazepine” and has now been corrected in the HTML and PDF versions of the article.
Competing interests
: The authors declare no competing interests.